{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T15:36:30Z","timestamp":1766504190831,"version":"3.48.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,23]]},"DOI":"10.7759\/cureus.99926","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T13:52:36Z","timestamp":1766497956000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic, Prognostic, and Immunomodulatory Roles of Prostaglandin E Receptor 1 (PTGER1): A Pan-Cancer Study"],"prefix":"10.7759","author":[{"given":"Rasha","family":"Suliman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Alfaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.r2022","article-title":"Cancer deaths expected to reach 18 million by 2050, major study forecasts","volume":"390","author":"Bowie K","year":"2025","unstructured":"Bowie K. Cancer deaths expected to reach 18 million by 2050, major study forecasts. BMJ. 2025, 390:r2022. 10.1136\/bmj.r2022","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/10495398.2013.826236","article-title":"Molecular cloning and expression analysis of prostaglandin E receptor 2 gene in cashmere goat (Capra hircus) skin during hair follicle development","volume":"25","author":"Geng RQ","year":"2014","unstructured":"Geng RQ, Yuan C, Chen YL. Molecular cloning and expression analysis of prostaglandin E receptor 2 gene in cashmere goat (Capra hircus) skin during hair follicle development. Anim Biotechnol. 2014, 25:98-107. 10.1080\/10495398.2013.826236","journal-title":"Anim Biotechnol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li T","year":"2017","unstructured":"Li T, Fan J, Wang B, et al.. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017, 77:e108-10. 10.1158\/0008-5472.CAN-17-0307","journal-title":"Cancer Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar DS","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, et al.. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia. 2022, 25:18-27. 10.1016\/j.neo.2022.01.001","journal-title":"Neoplasia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang Z","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019, 47:W556-60. 10.1093\/nar\/gkz430","journal-title":"Nucleic Acids Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami E","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, et al.. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012, 2:401-4. 10.1158\/2159-8290.CD-12-0095","journal-title":"Cancer Discov"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/419323a","article-title":"Microarray standards at last","volume":"419","year":"2002","unstructured":"Microarray standards at last. Nature. 2002, 419.323. 10.1038\/419323a","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"Gentleman RC","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM, et al.. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5:R80. 10.1186\/gb-2004-5-10-r80","journal-title":"Genome Biol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.1c00255","article-title":"Second-generation prostaglandin receptor EP2 antagonist, TG8-260, with high potency, selectivity, oral bioavailability, and anti-inflammatory properties","volume":"5","author":"Amaradhi R","year":"2022","unstructured":"Amaradhi R, Mohammed S, Banik A, Franklin R, Dingledine R, Ganesh T. Second-generation prostaglandin receptor EP2 antagonist, TG8-260, with high potency, selectivity, oral bioavailability, and anti-inflammatory properties. ACS Pharmacol Transl Sci. 2022, 5:118-33. 10.1021\/acsptsci.1c00255","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.86492","article-title":"The PTGS2\/COX2-PGE(2) signaling cascade in inflammation: pro or anti? A case study with type 1 diabetes mellitus","volume":"19","author":"Mart\u00edn-V\u00e1zquez E","year":"2023","unstructured":"Mart\u00edn-V\u00e1zquez E, Cobo-Vuilleumier N, L\u00f3pez-Noriega L, Lorenzo PI, Gauthier BR. The PTGS2\/COX2-PGE(2) signaling cascade in inflammation: pro or anti? A case study with type 1 diabetes mellitus. Int J Biol Sci. 2023, 19:4157-65. 10.7150\/ijbs.86492","journal-title":"Int J Biol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2490-12-35","article-title":"Identification of prostaglandin receptors in human ureters","volume":"12","author":"Oll M","year":"2012","unstructured":"Oll M, Baumann C, Behbahani TE, von Ruecker A, M\u00fcller SC, Ellinger J. Identification of prostaglandin receptors in human ureters. BMC Urol. 2012, 12:35. 10.1186\/1471-2490-12-35","journal-title":"BMC Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.31219\/osf.io\/7b3m8","article-title":"Differential expression of PTGER3 in cancer of the cervix [PREPRINT]","author":"Mamoor S","year":"2023","unstructured":"Mamoor S. Differential expression of PTGER3 in cancer of the cervix [PREPRINT]. 2023, 10.31219\/osf.io\/7b3m8"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.0005","article-title":"Intrinsic genomic differences between African American and White patients with clear cell renal cell carcinoma","volume":"2","author":"Krishnan B","year":"2016","unstructured":"Krishnan B, Rose TL, Kardos J, Milowsky MI, Kim WY. Intrinsic genomic differences between African American and White patients with clear cell renal cell carcinoma. JAMA Oncol. 2016, 2:664-7. 10.1001\/jamaoncol.2016.0005","journal-title":"JAMA Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16112001","article-title":"Current challenges of methylation-based liquid biopsies in cancer diagnostics","volume":"16","author":"Rendek T","year":"2024","unstructured":"Rendek T, Pos O, Duranova T, Saade R, Budis J, Repiska V, Szemes T. Current challenges of methylation-based liquid biopsies in cancer diagnostics. Cancers (Basel). 2024, 16:2001. 10.3390\/cancers16112001","journal-title":"Cancers (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2174\/9789815238037124010014","article-title":"Molecular basis of cancer","author":"Sarfraz M","year":"2024","unstructured":"Sarfraz M, Ullah H. Molecular basis of cancer. Fundamentals of Cellular and Molecular Biology. Bentham Science Publishers, 2024. 143-55. 10.2174\/9789815238037124010014"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(00)00303-8","article-title":"Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes","volume":"36","author":"Esteller M","year":"2000","unstructured":"Esteller M. Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes. Eur J Cancer. 2000, 36:2294-300. 10.1016\/S0959-8049(00)00303-8","journal-title":"Eur J Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23694","article-title":"Clinical significance of aberrant methylation of prostaglandin E receptor 2 (PTGER2) in nonsmall cell lung cancer: association with prognosis, PTGER2 expression, and epidermal growth factor receptor mutation","volume":"113","author":"Tian L","year":"2008","unstructured":"Tian L, Suzuki M, Nakajima T, et al.. Clinical significance of aberrant methylation of prostaglandin E receptor 2 (PTGER2) in nonsmall cell lung cancer: association with prognosis, PTGER2 expression, and epidermal growth factor receptor mutation. Cancer. 2008, 113:1396-403. 10.1002\/cncr.23694","journal-title":"Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-1804-1_1","article-title":"Cancer epigenetics: an introduction","volume":"1238","author":"Kanwal R","year":"2015","unstructured":"Kanwal R, Gupta K, Gupta S. Cancer epigenetics: an introduction. Methods Mol Biol. 2015, 1238:3-25. 10.1007\/978-1-4939-1804-1_1","journal-title":"Methods Mol Biol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20091921","article-title":"Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma","volume":"207","author":"Xie Y","year":"2010","unstructured":"Xie Y, Akpinarli A, Maris C, et al.. Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma. J Exp Med. 2010, 207:651-67. 10.1084\/jem.20091921","journal-title":"J Exp Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Hiam-Galvez KJ","year":"2021","unstructured":"Hiam-Galvez KJ, Allen BM, Spitzer MH. Systemic immunity in cancer. Nat Rev Cancer. 2021, 21:345-59. 10.1038\/s41568-021-00347-z","journal-title":"Nat Rev Cancer"},{"key":"ref21","article-title":"The role of CD8+ T-cells and their cytokines in the pathogenesis of psoriasis","volume":"27","author":"Volari\u0107 I","year":"2019","unstructured":"Volari\u0107 I, Vi\u010di\u0107 M, Prpi\u0107-Massari L. The role of CD8+ T-cells and their cytokines in the pathogenesis of psoriasis. Acta Dermatovenerol Croat. 2019, 27:159-62.","journal-title":"Acta Dermatovenerol Croat"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman WH","year":"2017","unstructured":"Fridman WH, Zitvogel L, Saut\u00e8s-Fridman C, Kroemer G. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 2017, 14:717-34. 10.1038\/nrclinonc.2017.101","journal-title":"Nat Rev Clin Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174495","article-title":"Neutrophil extracellular traps (NETs) in cancer invasion, evasion and metastasis","volume":"13","author":"Demkow U","year":"2021","unstructured":"Demkow U. Neutrophil extracellular traps (NETs) in cancer invasion, evasion and metastasis. Cancers (Basel). 2021, 13:4495. 10.3390\/cancers13174495","journal-title":"Cancers (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.123.000901","article-title":"Prostaglandin E2 in the tumor microenvironment, a convoluted affair mediated by EP receptors 2 and 4","volume":"76","author":"Santiso A","year":"2024","unstructured":"Santiso A, Heinemann A, Kargl J. Prostaglandin E2 in the tumor microenvironment, a convoluted affair mediated by EP receptors 2 and 4. Pharmacol Rev. 2024, 76:388-413. 10.1124\/pharmrev.123.000901","journal-title":"Pharmacol Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2003.09.031","article-title":"EP2 and EP4 prostanoid receptor signaling","volume":"74","author":"Regan JW","year":"2003","unstructured":"Regan JW. EP2 and EP4 prostanoid receptor signaling. Life Sci. 2003, 74:143-53. 10.1016\/j.lfs.2003.09.031","journal-title":"Life Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-018-9740-2","article-title":"Role of prostaglandins in tumor microenvironment","volume":"37","author":"Kobayashi K","year":"2018","unstructured":"Kobayashi K, Omori K, Murata T. Role of prostaglandins in tumor microenvironment. Cancer Metastasis Rev. 2018, 37:347-54. 10.1007\/s10555-018-9740-2","journal-title":"Cancer Metastasis Rev"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-02636-6_6","article-title":"Gene amplification and related events","author":"Nagl W","year":"1990","unstructured":"Nagl W. Gene amplification and related events. Somaclonal Variation in Crop Improvement I. Biotechnology in Agriculture and Forestry. Bajaj YPS (ed): Springer, Berlin, Heidelberg; 1990. 10.1007\/978-3-662-02636-6_6"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/00015458.2023.2180712","article-title":"Prognostic impact of CD4+ and CD8+ tumor-infiltrating lymphocytes in patients with colorectal cancer","volume":"124","author":"Tao Y","year":"2024","unstructured":"Tao Y, Xie Y. Prognostic impact of CD4+ and CD8+ tumor-infiltrating lymphocytes in patients with colorectal cancer. Acta Chir Belg. 2024, 124:35-40. 10.1080\/00015458.2023.2180712","journal-title":"Acta Chir Belg"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2809199","article-title":"N6-methyladenosine methyltransferase METTL3 enhances PTGER2 expression to increase ovarian cancer stemness and chemoresistance","volume":"28","author":"Lin YB","year":"2023","unstructured":"Lin YB, Xu BH. N6-methyladenosine methyltransferase METTL3 enhances PTGER2 expression to increase ovarian cancer stemness and chemoresistance. Front Biosci (Landmark Ed). 2023, 28:199. 10.31083\/j.fbl2809199","journal-title":"Front Biosci (Landmark Ed)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.112.100883","article-title":"Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms","volume":"88","author":"Lee J","year":"2013","unstructured":"Lee J, Banu SK, Burghardt RC, Starzinski-Powitz A, Arosh JA. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms. Biol Reprod. 2013, 88:77. 10.1095\/biolreprod.112.100883","journal-title":"Biol Reprod"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/434529-diagnostic-prognostic-and-immunomodulatory-roles-of-prostaglandin-e-receptor-1-ptger1-a-pan-cancer-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T13:52:37Z","timestamp":1766497957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/434529-diagnostic-prognostic-and-immunomodulatory-roles-of-prostaglandin-e-receptor-1-ptger1-a-pan-cancer-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.99926","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,23]]}}}